Skip to content

Effects of oliceridine on postoperative nausea and vomiting and gut microbiota in patients undergoing lumbar spine surgery

Effects of oliceridine on postoperative nausea and vomiting and gut microbiota in patients undergoing lumbar spine surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126947
Enrollment
Unknown
Registered
2026-06-20
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative nausea and vomiting (PONV)

Interventions

Sufentanil Group(Group S):Sufentanil is used for general anesthesia induction, intraoperative redosing, bridging, and postoperative analgesia.
Oliceridine Group(Group O).:Oliceridine is used for general anesthesia induction, intraoperative redosing, bridging, and postoperative analgesia.

Sponsors

The First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Obtaining informed consent. 2.Patients undergoing elective lumbar fusion surgery with 1–2 levels resected and operative duration of 1–3 hours. 3.Patients identified as at high risk for PONV according to the Apfel score (female, non-smoker, history of PONV/motion sickness, postoperative opioid use); those with 3–4 risk factors are classified as high-risk. 4.ASA physical status II–III; 5.Aged 18–65 years. 6.BMI 18–28 kg/m².

Exclusion criteria

Exclusion criteria: 1.History of allergy to oliceridine. 2.Use of other antiemetics or glucocorticoids within 24 hours before surgery. 3.Presence of severe underlying diseases, such as cardiovascular/cerebrovascular disease, respiratory disease, or severe liver/kidney dysfunction. 4.Poorly controlled diabetes or hypertension. 5.Gastrointestinal obstruction. 6.Patients with opioid addiction. 7.Inability to communicate normally (e.g., hearing impairment, language comprehension disorder, or psychiatric illness).

Design outcomes

Primary

MeasureTime frame
24?h postoperative nausea and vomiting (PONV) incidence.;

Secondary

MeasureTime frame
Hemodynamic indicators;Gut Microbiota;Opioid consumption (intraoperative and postoperative).;Frequency and severity of PONV within 24 hours postoperatively.;Adverse events;

Countries

China

Contacts

Public ContactQ Liangchao

The First Affiliated Hospital of Nanchang University

ndyfy03356@ncu.edu.cn+86 791 88385706

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 29, 2026